Closed · DE-FOA-0002532 · CFDA 81.049 · Discretionary

Advancing Novel Medical Isotopes for Clinical Trials

Federal grant opportunity posted by Office of Science, cataloged on Grants.gov.

$100K-$500K
Award range
Closed
Status
July 23, 2021
Close date
-
Expected awards

The verdict

Advancing Novel Medical Isotopes for Clinical Trials is a closed discretionary listing from Office of Science that offered $100,000 -- $500,000. Future funding cycles may be published under the same CFDA number.

$100K-$500K
award range
Closed
application status
81.049
CFDA program

Opportunity snapshot. This Grants.gov announcement - Advancing Novel Medical Isotopes for Clinical Trials - is cataloged under number DE-FOA-0002532 and tied to CFDA assistance listing 81.049, posted by Office of Science. Grants.gov currently shows the opportunity as closed, first posted on June 1, 2021. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is $100,000 -- $500,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on July 23, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

$100,000 -- $500,000

Close Date

July 23, 2021

Posted

June 1, 2021

Instrument

Grant

Description

The DOE SC program in Isotope R&D and Production (DOE IP) hereby announces its interest in receiving applications for research to facilitate, streamline, and accelerate the translation of novel radioisotopes and their associated chelating agents and linker/ligands, for both diagnosis and treatment, from the laboratory bench to evaluation for potential usage in clinical and pre-clinical trials. Evaluating these materials for use in clinical and pre-clinical trials is beyond the scope of this FOA as well as outside the mission of the DOE IP: Applications requesting support for such evaluations will be declined without merit review. Successful applications would benefit the public by leveraging the scientific and technical capabilities of existing facilities at institutions of higher education, non-profit research institutions, and DOE/National Nuclear Security Administration (NNSA) National Laboratories to accelerate the development process for new diagnostic and therapeutic agents. Applications focused on aspects of isotope R&D not associated with translational research are outside the scope of this FOA and will be declined without merit review. Applications are restricted to recently-developed medical isotopes by the DOE IP (listed on the next page) but are not restricted in chelator/ligand technology. Applications incorporating effective ways to train personnel with essential knowledge and skills related to the production, processing, purification, and distribution of enriched stable and radioactive isotopes are strongly encouraged. While this FOA is administered by the DOE IP, the assessment of submitted proposals will be in coordination with the National Institutes of Health.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 06, 20, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Ethan Balkin, Ph.D. Program Manger Phone 301-903-1861

Key Dates

Posted June 1, 2021
Close Date July 23, 2021
Archive Date August 22, 2021
Last Updated June 1, 2021

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Advancing Novel Medical Isotopes for Clinical Trials", offered by Office of Science. It is associated with CFDA program 81.049. The DOE SC program in Isotope R&D and Production (DOE IP) hereby announces its interest in receiving applications for research to facilitate, streamline, and accelerate the translation of novel radioi...
Is this opportunity still open?
No, this opportunity is closed. It closed on July 23, 2021. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is $100,000 -- $500,000.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants